HEADER HYDROLASE 22-NOV-07 3BFO TITLE CRYSTAL STRUCTURE OF IG-LIKE C2-TYPE 2 DOMAIN OF THE HUMAN MUCOSA- TITLE 2 ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION COMPND 3 PROTEIN 1 (ISOFORM 2); COMPND 4 CHAIN: A, B, C, D; COMPND 5 FRAGMENT: IG-LIKE C2-TYPE 2 DOMAIN: RESIDUES 226-314 OF ISOFORM 2 COMPND 6 (Q9UDY8-2); COMPND 7 SYNONYM: MALT LYMPHOMA-ASSOCIATED TRANSLOCATION, PARACASPASE; COMPND 8 EC: 3.4.22.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MALT1, MLT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-LIC KEYWDS HYDROLASE, IMMUNOGLOBULIN DOMAIN, NUCLEUS, PROTEASE, UBL CONJUGATION KEYWDS 2 PATHWAY, STRUCTURAL GENOMICS CONSORTIUM, SGC, ALTERNATIVE SPLICING, KEYWDS 3 CHROMOSOMAL REARRANGEMENT, CYTOPLASM EXPDTA X-RAY DIFFRACTION AUTHOR J.R.WALKER,M.AKUTSU,D.R.LITTLER,Y.LI,J.WEIGELT,C.H.ARROWSMITH, AUTHOR 2 A.M.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 3 (SGC) REVDAT 3 30-AUG-23 3BFO 1 SEQADV REVDAT 2 24-FEB-09 3BFO 1 VERSN REVDAT 1 11-DEC-07 3BFO 0 JRNL AUTH J.R.WALKER,M.AKUTSU,D.R.LITTLER,Y.LI,J.WEIGELT, JRNL AUTH 2 C.H.ARROWSMITH,A.M.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON JRNL TITL STRUCTURE OF THE IG-LIKE C2-TYPE 2 DOMAIN OF THE HUMAN JRNL TITL 2 MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION JRNL TITL 3 PROTEIN 1. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 98073 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5145 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.18 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7040 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.66 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 379 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2746 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 398 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.93000 REMARK 3 B22 (A**2) : -0.67000 REMARK 3 B33 (A**2) : -0.76000 REMARK 3 B12 (A**2) : 0.17000 REMARK 3 B13 (A**2) : -0.19000 REMARK 3 B23 (A**2) : 0.63000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.048 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.047 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.031 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.486 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.962 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3153 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4343 ; 1.830 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 410 ; 7.170 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 124 ;32.076 ;25.161 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 579 ;13.739 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;23.895 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 475 ; 0.128 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2438 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1408 ; 0.226 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2213 ; 0.313 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 297 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 102 ; 0.232 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 48 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1990 ; 2.535 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3226 ; 3.337 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1361 ; 4.006 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1117 ; 5.090 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3351 ; 2.792 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 401 ; 9.706 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3040 ; 6.543 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3BFO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045461. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91790 REMARK 200 MONOCHROMATOR : HORIZONTAL BENT SI(111), REMARK 200 ASYMMETRICALLY CUT WITH WATER REMARK 200 COOLED CU BLOCK REMARK 200 OPTICS : RH COATED SI MONOCHROMATIC REMARK 200 MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103829 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.150 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.65100 REMARK 200 FOR SHELL : 2.480 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRIES 1U2H, 2AW2, 1CS6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:1 VOLUME RATIO OF PROTEIN SOLUTION REMARK 280 (50 MG/ML) AND RESERVOIR SOLUTION (30% PEG MME 550, 0.2 M REMARK 280 AMMONIUM SULFATE, 0.1 M SODIUM CACODYLATE PH 6.5), VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 224 REMARK 465 GLU A 310 REMARK 465 LEU A 311 REMARK 465 ASN A 312 REMARK 465 ASN A 313 REMARK 465 LEU A 314 REMARK 465 GLY B 224 REMARK 465 GLU B 310 REMARK 465 LEU B 311 REMARK 465 ASN B 312 REMARK 465 ASN B 313 REMARK 465 LEU B 314 REMARK 465 GLY C 224 REMARK 465 GLU C 310 REMARK 465 LEU C 311 REMARK 465 ASN C 312 REMARK 465 ASN C 313 REMARK 465 LEU C 314 REMARK 465 GLY D 224 REMARK 465 GLU D 310 REMARK 465 LEU D 311 REMARK 465 ASN D 312 REMARK 465 ASN D 313 REMARK 465 LEU D 314 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 237 CE NZ REMARK 470 HIS A 269 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 303 NZ REMARK 470 ASP A 309 CG OD1 OD2 REMARK 470 HIS B 269 CG ND1 CD2 CE1 NE2 REMARK 470 ASP C 309 CG OD1 OD2 REMARK 470 ASP D 309 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL C 280 CB VAL C 280 CG1 -0.139 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G7R RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE DEATH DOMAIN OF THE HUMAN MUCOSA ASSOCIATED REMARK 900 LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 DBREF 3BFO A 226 314 UNP Q9UDY8 MALT1_HUMAN 226 314 DBREF 3BFO B 226 314 UNP Q9UDY8 MALT1_HUMAN 226 314 DBREF 3BFO C 226 314 UNP Q9UDY8 MALT1_HUMAN 226 314 DBREF 3BFO D 226 314 UNP Q9UDY8 MALT1_HUMAN 226 314 SEQADV 3BFO GLY A 224 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO SER A 225 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO GLY B 224 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO SER B 225 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO GLY C 224 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO SER C 225 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO GLY D 224 UNP Q9UDY8 EXPRESSION TAG SEQADV 3BFO SER D 225 UNP Q9UDY8 EXPRESSION TAG SEQRES 1 A 91 GLY SER LYS LEU GLN ILE CYS VAL GLU PRO THR SER GLN SEQRES 2 A 91 LYS LEU MET PRO GLY SER THR LEU VAL LEU GLN CYS VAL SEQRES 3 A 91 ALA VAL GLY SER PRO ILE PRO HIS TYR GLN TRP PHE LYS SEQRES 4 A 91 ASN GLU LEU PRO LEU THR HIS GLU THR LYS LYS LEU TYR SEQRES 5 A 91 MET VAL PRO TYR VAL ASP LEU GLU HIS GLN GLY THR TYR SEQRES 6 A 91 TRP CYS HIS VAL TYR ASN ASP ARG ASP SER GLN ASP SER SEQRES 7 A 91 LYS LYS VAL GLU ILE ILE ILE ASP GLU LEU ASN ASN LEU SEQRES 1 B 91 GLY SER LYS LEU GLN ILE CYS VAL GLU PRO THR SER GLN SEQRES 2 B 91 LYS LEU MET PRO GLY SER THR LEU VAL LEU GLN CYS VAL SEQRES 3 B 91 ALA VAL GLY SER PRO ILE PRO HIS TYR GLN TRP PHE LYS SEQRES 4 B 91 ASN GLU LEU PRO LEU THR HIS GLU THR LYS LYS LEU TYR SEQRES 5 B 91 MET VAL PRO TYR VAL ASP LEU GLU HIS GLN GLY THR TYR SEQRES 6 B 91 TRP CYS HIS VAL TYR ASN ASP ARG ASP SER GLN ASP SER SEQRES 7 B 91 LYS LYS VAL GLU ILE ILE ILE ASP GLU LEU ASN ASN LEU SEQRES 1 C 91 GLY SER LYS LEU GLN ILE CYS VAL GLU PRO THR SER GLN SEQRES 2 C 91 LYS LEU MET PRO GLY SER THR LEU VAL LEU GLN CYS VAL SEQRES 3 C 91 ALA VAL GLY SER PRO ILE PRO HIS TYR GLN TRP PHE LYS SEQRES 4 C 91 ASN GLU LEU PRO LEU THR HIS GLU THR LYS LYS LEU TYR SEQRES 5 C 91 MET VAL PRO TYR VAL ASP LEU GLU HIS GLN GLY THR TYR SEQRES 6 C 91 TRP CYS HIS VAL TYR ASN ASP ARG ASP SER GLN ASP SER SEQRES 7 C 91 LYS LYS VAL GLU ILE ILE ILE ASP GLU LEU ASN ASN LEU SEQRES 1 D 91 GLY SER LYS LEU GLN ILE CYS VAL GLU PRO THR SER GLN SEQRES 2 D 91 LYS LEU MET PRO GLY SER THR LEU VAL LEU GLN CYS VAL SEQRES 3 D 91 ALA VAL GLY SER PRO ILE PRO HIS TYR GLN TRP PHE LYS SEQRES 4 D 91 ASN GLU LEU PRO LEU THR HIS GLU THR LYS LYS LEU TYR SEQRES 5 D 91 MET VAL PRO TYR VAL ASP LEU GLU HIS GLN GLY THR TYR SEQRES 6 D 91 TRP CYS HIS VAL TYR ASN ASP ARG ASP SER GLN ASP SER SEQRES 7 D 91 LYS LYS VAL GLU ILE ILE ILE ASP GLU LEU ASN ASN LEU FORMUL 5 HOH *398(H2 O) HELIX 1 1 ASP A 281 GLN A 285 5 5 HELIX 2 2 ASP B 281 GLN B 285 5 5 HELIX 3 3 ASP C 281 GLN C 285 5 5 HELIX 4 4 ASP D 281 GLN D 285 5 5 SHEET 1 A 2 GLN A 228 VAL A 231 0 SHEET 2 A 2 VAL A 249 VAL A 251 -1 O VAL A 249 N CYS A 230 SHEET 1 B 5 GLN A 236 LEU A 238 0 SHEET 2 B 5 VAL A 304 ILE A 308 1 O ILE A 307 N LEU A 238 SHEET 3 B 5 GLY A 286 TYR A 293 -1 N TYR A 288 O VAL A 304 SHEET 4 B 5 HIS A 257 LYS A 262 -1 N HIS A 257 O TYR A 293 SHEET 5 B 5 LEU A 265 PRO A 266 -1 O LEU A 265 N LYS A 262 SHEET 1 C 4 GLN A 236 LEU A 238 0 SHEET 2 C 4 VAL A 304 ILE A 308 1 O ILE A 307 N LEU A 238 SHEET 3 C 4 GLY A 286 TYR A 293 -1 N TYR A 288 O VAL A 304 SHEET 4 C 4 SER A 298 ASP A 300 -1 O GLN A 299 N VAL A 292 SHEET 1 D 2 LEU A 244 GLN A 247 0 SHEET 2 D 2 LEU A 274 VAL A 277 -1 O TYR A 275 N LEU A 246 SHEET 1 E 2 GLN B 228 VAL B 231 0 SHEET 2 E 2 VAL B 249 VAL B 251 -1 O VAL B 249 N CYS B 230 SHEET 1 F 5 GLN B 236 LEU B 238 0 SHEET 2 F 5 VAL B 304 ILE B 308 1 O ILE B 307 N LEU B 238 SHEET 3 F 5 GLY B 286 TYR B 293 -1 N GLY B 286 O ILE B 306 SHEET 4 F 5 HIS B 257 LYS B 262 -1 N PHE B 261 O TRP B 289 SHEET 5 F 5 LEU B 265 PRO B 266 -1 O LEU B 265 N LYS B 262 SHEET 1 G 4 GLN B 236 LEU B 238 0 SHEET 2 G 4 VAL B 304 ILE B 308 1 O ILE B 307 N LEU B 238 SHEET 3 G 4 GLY B 286 TYR B 293 -1 N GLY B 286 O ILE B 306 SHEET 4 G 4 SER B 298 ASP B 300 -1 O GLN B 299 N VAL B 292 SHEET 1 H 2 LEU B 244 GLN B 247 0 SHEET 2 H 2 LEU B 274 VAL B 277 -1 O TYR B 275 N LEU B 246 SHEET 1 I 2 GLN C 228 VAL C 231 0 SHEET 2 I 2 VAL C 249 VAL C 251 -1 O VAL C 249 N CYS C 230 SHEET 1 J 5 GLN C 236 LEU C 238 0 SHEET 2 J 5 VAL C 304 ILE C 308 1 O ILE C 307 N LEU C 238 SHEET 3 J 5 GLY C 286 TYR C 293 -1 N GLY C 286 O ILE C 306 SHEET 4 J 5 HIS C 257 LYS C 262 -1 N HIS C 257 O TYR C 293 SHEET 5 J 5 LEU C 265 PRO C 266 -1 O LEU C 265 N LYS C 262 SHEET 1 K 4 GLN C 236 LEU C 238 0 SHEET 2 K 4 VAL C 304 ILE C 308 1 O ILE C 307 N LEU C 238 SHEET 3 K 4 GLY C 286 TYR C 293 -1 N GLY C 286 O ILE C 306 SHEET 4 K 4 SER C 298 ASP C 300 -1 O GLN C 299 N VAL C 292 SHEET 1 L 2 LEU C 244 GLN C 247 0 SHEET 2 L 2 LEU C 274 VAL C 277 -1 O VAL C 277 N LEU C 244 SHEET 1 M 2 GLN D 228 VAL D 231 0 SHEET 2 M 2 VAL D 249 VAL D 251 -1 O VAL D 249 N CYS D 230 SHEET 1 N 5 GLN D 236 LEU D 238 0 SHEET 2 N 5 VAL D 304 ILE D 308 1 O ILE D 307 N LEU D 238 SHEET 3 N 5 GLY D 286 TYR D 293 -1 N GLY D 286 O ILE D 306 SHEET 4 N 5 HIS D 257 LYS D 262 -1 N PHE D 261 O TRP D 289 SHEET 5 N 5 LEU D 265 PRO D 266 -1 O LEU D 265 N LYS D 262 SHEET 1 O 4 GLN D 236 LEU D 238 0 SHEET 2 O 4 VAL D 304 ILE D 308 1 O ILE D 307 N LEU D 238 SHEET 3 O 4 GLY D 286 TYR D 293 -1 N GLY D 286 O ILE D 306 SHEET 4 O 4 SER D 298 ASP D 300 -1 O GLN D 299 N VAL D 292 SHEET 1 P 2 LEU D 244 GLN D 247 0 SHEET 2 P 2 LEU D 274 VAL D 277 -1 O VAL D 277 N LEU D 244 CISPEP 1 SER A 253 PRO A 254 0 1.23 CISPEP 2 SER B 253 PRO B 254 0 2.85 CISPEP 3 SER C 253 PRO C 254 0 0.85 CISPEP 4 SER D 253 PRO D 254 0 1.39 CRYST1 39.944 43.640 49.595 66.50 90.00 90.02 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025035 0.000008 -0.000006 0.00000 SCALE2 0.000000 0.022915 -0.009965 0.00000 SCALE3 0.000000 0.000000 0.021987 0.00000